Increased levels of PINK1 in the primary stages of Alzheimer’s disease (AD) and elevated Parkin levels in the final stages of the disease have been detected in the hippocampi of patients with sporadic AD [79]. This evidence concerns the gene PINK1 and Alzheimer disease.